Phyllissa Schmiedlin‐Ren
- Pharmacology top 0.1%
- Pharmacogenetics and Drug Metabolism 11
- Drug-Induced Hepatotoxicity and Protection 3
- Transplantation top 2%
- Oncology top 2%
- Drug Transport and Resistance Mechanisms 6
-
- Pharmacological Effects and Toxicity Studies 4
- Pharmaceutical Science top 5%
-
- Inflammatory Bowel Disease 11
- Virus-based gene therapy research 4
-
- Viral gastroenteritis research and epidemiology 4
-
- Autoimmune and Inflammatory Disorders 3
- Co-authors
- Paul B. WatkinsKenneth S. LownJoseph C. KolarsKenneth E. ThummelJohn D. SchuetzMary F. PaineJeannine M. FisherWen-Sheng Guo
- Cited by
- PharmacologyTransplantationOncology
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Phyllissa Schmiedlin‐Ren
30 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Pharmacology 1.3k
- Transplantation 216
- Oncology 1.3k
- Pediatrics, Perinatology and Child Health 739
- Pharmaceutical Science 105
Countries citing papers authored by Phyllissa Schmiedlin‐Ren
This map shows the geographic impact of Phyllissa Schmiedlin‐Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phyllissa Schmiedlin‐Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phyllissa Schmiedlin‐Ren more than expected).
Fields of papers citing papers by Phyllissa Schmiedlin‐Ren
This network shows the impact of papers produced by Phyllissa Schmiedlin‐Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phyllissa Schmiedlin‐Ren. The network helps show where Phyllissa Schmiedlin‐Ren may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Phyllissa Schmiedlin‐Ren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 13 | |
| 2 | 2013 | 38 | |
| 3 | 2011 | 75 | |
| 4 | 2011 | 123 | |
| 5 | 2011 | 31 | |
| 6 | 2011 | 1 | |
| 7 | 2010 | 17 | |
| 8 | 2006 | 10 | |
| 9 | 2005 | 7 | |
| 10 | The furocoumarin 6',7'-dihydroxybergamottin (DHB) accelerates CYp3A4 degradation via the ubiquitin-proteasomal pathway. | 2001 | 6 |
| 11 | 1999 | 34 | |
| 12 | 1999 | 70 | |
| 13 | Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine*breakdown → | 1997 | 576 |
| 14 | 1997 | 276 | |
| 15 | 1996 | 38 | |
| 16 | 1994 | 321 | |
| 17 | 1994 | 32 | |
| 18 | 1993 | 22 | |
| 19 | 1992 | 447 | |
| 20 | 1992 | 60 |
About Phyllissa Schmiedlin‐Ren
Phyllissa Schmiedlin‐Ren is a scholar working on Pharmacology, Genetics and Transplantation, having authored 31 papers that have together received 2.5k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (11 papers), Inflammatory Bowel Disease (11 papers), Drug Transport and Resistance Mechanisms (6 papers), Viral gastroenteritis research and epidemiology (4 papers), Virus-based gene therapy research (4 papers), Pharmacological Effects and Toxicity Studies (4 papers), Drug-Induced Hepatotoxicity and Protection (3 papers) and Autoimmune and Inflammatory Disorders (3 papers). The work is most often cited by research in Pharmacology (1.3k citations), Transplantation (216 citations) and Oncology (1.3k citations). Phyllissa Schmiedlin‐Ren has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Paul B. Watkins, Kenneth S. Lown, Joseph C. Kolars, Kenneth E. Thummel, John D. Schuetz, Mary F. Paine, Jeannine M. Fisher, Paul B. Watkins, Wen-Sheng Guo and Steven Wrighton. Their work appears in journals such as Journal of Clinical Investigation, Gastroenterology and Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.